The lack of a rescue therapy should not be a deal-breaker for properly conducted challenge trials aimed at thoroughly evaluating COVID-19 vaccines, write Nir Eyal and Bastian Steuwer.
COVID-19 vaccine race is a long way from over, and human challenge trials still have a role to play
Post a Comment